SYNERGIA MEDICAL OBTAINS BELGIUM HEALTH AUTHORITY APPROVAL TO START FIRST IN HUMAN CLINICAL STUDY
Synergia Medical to start NAO.VNS FIH study, the first quartz optoelectronic neurostimulator for the treatment of drug-resistant epilepsy. BRUSSELS, BELGIUM, April 29, 2024 /EINPresswire.com/ -- Synergia Medical, a clinical medical device …